These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 21380408)

  • 1. Towards translation of 212Pb as a clinical therapeutic; getting the lead in!
    Yong K; Brechbiel MW
    Dalton Trans; 2011 Jun; 40(23):6068-76. PubMed ID: 21380408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promise of targeted {alpha}-particle therapy.
    Mulford DA; Scheinberg DA; Jurcic JG
    J Nucl Med; 2005 Jan; 46 Suppl 1():199S-204S. PubMed ID: 15653670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted alpha-therapy: past, present, future?
    Brechbiel MW
    Dalton Trans; 2007 Nov; (43):4918-28. PubMed ID: 17992276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of
    Yong K; Brechbiel M
    AIMS Med Sci; 2015; 2(3):228-245. PubMed ID: 26858987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted alpha therapy: part I.
    Elgqvist J
    Curr Radiopharm; 2011 Jul; 4(3):176. PubMed ID: 22201706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An overview of targeted alpha therapy.
    Kim YS; Brechbiel MW
    Tumour Biol; 2012 Jun; 33(3):573-90. PubMed ID: 22143940
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Li M; Sagastume EA; Lee D; McAlister D; DeGraffenreid AJ; Olewine KR; Graves S; Copping R; Mirzadeh S; Zimmerman BE; Larsen RH; Johnson FL; Schultz MK
    Curr Med Chem; 2020; 27(41):7003-7031. PubMed ID: 32720598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer radioimmunotherapy with alpha-emitting nuclides.
    Couturier O; Supiot S; Degraef-Mougin M; Faivre-Chauvet A; Carlier T; Chatal JF; Davodeau F; Cherel M
    Eur J Nucl Med Mol Imaging; 2005 May; 32(5):601-14. PubMed ID: 15841373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radioimmunotherapy of cancer with high linear energy transfer (LET) radiation delivered by radionuclides emitting α-particles or Auger electrons.
    Aghevlian S; Boyle AJ; Reilly RM
    Adv Drug Deliv Rev; 2017 Jan; 109():102-118. PubMed ID: 26705852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metal-Free Cycloaddition Chemistry Driven Pretargeted Radioimmunotherapy Using α-Particle Radiation.
    Shah MA; Zhang X; Rossin R; Robillard MS; Fisher DR; Bueltmann T; Hoeben FJM; Quinn TP
    Bioconjug Chem; 2017 Dec; 28(12):3007-3015. PubMed ID: 29129050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status and perspectives in alpha radioimmunotherapy.
    Chérel M; Davodeau F; Kraeber-Bodéré F; Chatal JF
    Q J Nucl Med Mol Imaging; 2006 Dec; 50(4):322-9. PubMed ID: 17043629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drugs That Modify Cholesterol Metabolism Alter the p38/JNK-Mediated Targeted and Nontargeted Response to Alpha and Auger Radioimmunotherapy.
    Ladjohounlou R; Lozza C; Pichard A; Constanzo J; Karam J; Le Fur P; Deshayes E; Boudousq V; Paillas S; Busson M; Le Blay M; Jarlier M; Marcatili S; Bardiès M; Bruchertseifer F; Morgenstern A; Torgue J; Navarro-Teulon I; Pouget JP
    Clin Cancer Res; 2019 Aug; 25(15):4775-4790. PubMed ID: 31061069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: therapeutic efficacy and dose-limiting toxicity of 213Bi- versus 90Y-labeled CO17-1A Fab' fragments in a human colonic cancer model.
    Behr TM; Béhé M; Stabin MG; Wehrmann E; Apostolidis C; Molinet R; Strutz F; Fayyazi A; Wieland E; Gratz S; Koch L; Goldenberg DM; Becker W
    Cancer Res; 1999 Jun; 59(11):2635-43. PubMed ID: 10363986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts.
    Yong KJ; Milenic DE; Baidoo KE; Brechbiel MW
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pretargeted radioimmunotherapy in tumored mice using an in vivo 212Pb/212Bi generator.
    Su FM; Beaumier P; Axworthy D; Atcher R; Fritzberg A
    Nucl Med Biol; 2005 Oct; 32(7):741-7. PubMed ID: 16243650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioimmunotherapy with α-particle-emitting radionuclides.
    Seidl C
    Immunotherapy; 2014; 6(4):431-58. PubMed ID: 24815783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicity and relative biological effectiveness of alpha emitting radioimmunoconjugates.
    Dahle J; Abbas N; Bruland ØS; Larsen RH
    Curr Radiopharm; 2011 Oct; 4(4):321-8. PubMed ID: 22202154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioimmunotherapy with alpha-particle emitting radionuclides.
    Zalutsky MR; Pozzi OR
    Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):289-96. PubMed ID: 15640792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha radioimmunotherapy using
    Cheal SM; McDevitt MR; Santich BH; Patel M; Yang G; Fung EK; Veach DR; Bell M; Ahad A; Vargas DB; Punzalan B; Pillarsetty NVK; Xu H; Guo HF; Monette S; Michel AO; Piersigilli A; Scheinberg DA; Ouerfelli O; Cheung NV; Larson SM
    Theranostics; 2020; 10(25):11359-11375. PubMed ID: 33052220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS.
    Rösch F; Baum RP
    Dalton Trans; 2011 Jun; 40(23):6104-11. PubMed ID: 21445433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.